Cabergoline Ratiopharm

Cabergoline Ratiopharm is a medication used primarily for conditions related to hyperprolactinemia. It works by reducing the levels of prolactin, a hormone that can cause various health issues. This oral medication is manufactured by Ratiopharm GmbH.

Cabergoline is commonly used to treat hyperprolactinemia, a condition where the body produces too much prolactin. This can lead to symptoms such as irregular menstrual cycles, infertility, and galactorrhea. Additionally, cabergoline may be prescribed for conditions like Parkinson's disease to manage symptoms. The primary use of cabergoline is to regulate prolactin levels and alleviate associated symptoms.

Common effects of cabergoline may include nausea, dizziness, and headaches. Some users might experience digestive issues or fatigue. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Cabergoline should be handled with care, especially for individuals with a history of heart valve disorders. It is important to follow the prescribed dosage and administration instructions. Pregnant or breastfeeding women should consult a healthcare provider before using cabergoline.

Cabergoline may interact with certain medications, including those that affect liver enzymes. Alcohol consumption should be avoided as it can enhance the sedative effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.